Arbaclofen ER

arbaclofen ER · RVL Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Arbaclofen ER, covering 2022-04-27 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis [Phase 3]

See pricing